49 related articles for article (PubMed ID: 4034045)
1. [Renal tolerance of an incremental dosage regimen of anturan in the aged with altered renal function]].
Bertolini G; Naliato P; Borghi C
Minerva Med; 1985 Aug; 76(32-33):1463-7. PubMed ID: 4034045
[TBL] [Abstract][Full Text] [Related]
2. Sulphinpyrazone in cardiovascular elderly azotemic patients: a proposal of a 'guided' incremental dose schedule.
Palummeri E; Borghi C; Di Ruvo R; Dacco' L; Passeri M
J Int Med Res; 1984; 12(5):271-6. PubMed ID: 6500166
[TBL] [Abstract][Full Text] [Related]
3. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients.
Caspi D; Lubart E; Graff E; Habot B; Yaron M; Segal R
Arthritis Rheum; 2000 Jan; 43(1):103-8. PubMed ID: 10643705
[TBL] [Abstract][Full Text] [Related]
4. Renal effects of low dose aspirin in elderly patients.
Segal R; Lubart E; Leibovitz A; Iaina A; Caspi D
Isr Med Assoc J; 2006 Oct; 8(10):679-82. PubMed ID: 17125112
[TBL] [Abstract][Full Text] [Related]
5. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
6. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
[TBL] [Abstract][Full Text] [Related]
7. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
[TBL] [Abstract][Full Text] [Related]
8. [Incremental doses of diltiazem in patients with coronary artery disease in end-stage renal failure maintained on hemodialysis: which is the optimal dose?].
Cice G; Ferrara L; Tagliamonte E; Di Benedetto A; Iacono A
Cardiologia; 1998 Dec; 43(12):1337-43. PubMed ID: 9988942
[TBL] [Abstract][Full Text] [Related]
9. Effect of drug-induced hyperuricaemia on renal function in Nigerians with pulmonary tuberculosis.
Adebisi SA; Oluboyo PO; Okesina AB
Afr J Med Med Sci; 2000; 29(3-4):297-300. PubMed ID: 11714010
[TBL] [Abstract][Full Text] [Related]
10. Conversion to microemulsion cyclosporine in stable renal transplant patients: results after one year.
Neumayer HH; Budde K; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J; Luft FC
Clin Nephrol; 1996 May; 45(5):326-31. PubMed ID: 8738665
[TBL] [Abstract][Full Text] [Related]
11. Re-establishment of erythropoietin responsiveness in end-stage renal failure following renal transplantation.
Jeffrey RF; Kendall RG; Prabhu P; Norfolk DR; Will EJ; Davison AM
Clin Nephrol; 1995 Oct; 44(4):241-7. PubMed ID: 8575124
[TBL] [Abstract][Full Text] [Related]
12. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease.
Besarab A; Salifu MO; Lunde NM; Bansal V; Fishbane S; Dougherty FC; Beyer U;
Clin Ther; 2007 Apr; 29(4):626-39. PubMed ID: 17617286
[TBL] [Abstract][Full Text] [Related]
14. Age-related differences in renal function at onset of renal replacement therapy in chronic kidney disease stage 5 patients.
Balogun SA; Balogun RA; Evans J
QJM; 2006 Sep; 99(9):595-9. PubMed ID: 16905750
[TBL] [Abstract][Full Text] [Related]
15. [Clinical aspects and renal function in patients with endemic nephropathy].
Bukvić D; Djukanović L; Janković S
Srp Arh Celok Lek; 2003; 131(1-2):10-6. PubMed ID: 14608855
[TBL] [Abstract][Full Text] [Related]
16. Effect of dopamine on renal function after arteriography in patients with pre-existing renal insufficiency.
Hans SS; Hans BA; Dhillon R; Dmuchowski C; Glover J
Am Surg; 1998 May; 64(5):432-6. PubMed ID: 9585778
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the tolerance and effectiveness of Diltiazem LP 300 mg in hypertensive patients with chronic renal insufficiency].
Bernadet-Monrozies P; Poilleux E; Suc JM
Ann Cardiol Angeiol (Paris); 1998 Oct; 47(8):589-94. PubMed ID: 9809145
[TBL] [Abstract][Full Text] [Related]
18. Renal tolerability of four different once-daily dose regimen of netilmicin in critical care patients.
Laczika K; Staudinger T; Hollenstein U; Presterl E; Locker GJ; Knapp S; Burgmann H; Stoiser B; Kofler J; Winter W; Graninger W; Frass M
Wien Klin Wochenschr; 1997 Nov; 109(21):840-4. PubMed ID: 9408981
[TBL] [Abstract][Full Text] [Related]
19. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
Giri S; Mahajan SK; Sen R; Sharma A
J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]